Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Nabriva Therapeutics
Pharma
Sanofi hits pause on rare disease candidate after FDA rejection
Sanofi is pressing pause on a rare disease candidate after the FDA found issues at a contract manufacturer's plant.
Kyle Blankenship
Nov 16, 2020 10:42am
Nabriva hit with 2nd FDA complete response letter for Contepo
Jun 22, 2020 10:00am
Nabriva scores its first FDA nod with novel antibiotic Xenleta
Aug 19, 2019 12:26pm